Article Information
History
- December 18, 2019.
Article Versions
- Version 1 (January 11, 2019 - 21:15).
- Version 2 (April 11, 2019 - 23:27).
- Version 3 (April 25, 2019 - 21:37).
- You are currently viewing Version 4 of this article (December 18, 2019 - 10:17).
- View Version 5, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Joshua J Carter1,
- Timothy M Walker1,
- A Sarah Walker1,2,
- Michael G. Whitfield3,‡,
- Glenn P. Morlock4,
- Timothy EA Peto1,2,
- James E. Posey4,
- Derrick W Crook1,2,5 and
- Philip W Fowler1,2,*
- 1Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK
- 2National Institute of Health Research Oxford Biomedical Research Centre, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK
- 3Division of Molecular Biology and Human Genetics, SAMRC Centre for Tuberculosis Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa
- 4Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States
- 5NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, UK
- ↵*Corresponding author and Lead Contact: philip.fowler{at}ndm.ox.ac.uk, @philipwfowler